SEC Form 4 · accession 0001179110-18-014133
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael A. Sherman
Officer — President and CEO · Director
Period of report
Dec 17, 2018
Accepted (ET)
Dec 19, 2018 · 4:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 17, 2018 | M | 5,330 | $2.54 | A | 353,248 | D | |
| Common Stock | Dec 17, 2018 | M | 10,035 | $2.54 | A | 363,283 | D | |
| Common Stock | Dec 17, 2018 | M | 15,706 | $3.82 | A | 378,989 | D | |
| Common Stock | Dec 17, 2018 | M | 39,200 | $9.05 | A | 418,189 | D | |
| Common Stock | Dec 17, 2018 | M | 25,002 | $3.55 | A | 443,191 | D | |
| Common Stock | Dec 17, 2018 | M | 11,281 | $9.86 | A | 454,472 | D | |
| Common Stock | Dec 17, 2018 | M | 9,000 | $11.11 | A | 463,472 | D | |
| Common Stock | Dec 17, 2018 | M | 3 | $5.10 | A | 463,475 | D | |
| Common Stock | Dec 17, 2018 | M | 2 | $3.18 | A | 463,477 | D | |
| Common StockF1 | Dec 17, 2018 | G | 84,112 | $0.00 | D | 379,365 | D | |
| Common Stock | holding | — | — | — | 19,919 | I | By Sherman Investors, LLC |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $2.54 | Dec 17, 2018 | M | 5,330 | D | — | Mar 5, 2019 | Common Stock | 5,330 | 0 | D |
| Stock option (right to buy)F2 | $2.54 | Dec 17, 2018 | M | 10,035 | D | — | Nov 12, 2019 | Common Stock | 10,035 | 0 | D |
| Stock Option (right to buy)F2 | $3.82 | Dec 17, 2018 | M | 15,706 | D | — | Feb 11, 2020 | Common Stock | 15,706 | 0 | D |
| Stock Option (right to buy)F2 | $9.05 | Dec 17, 2018 | M | 39,200 | D | — | Apr 14, 2021 | Common Stock | 39,200 | 20,800 | D |
| Stock option (right to buy)F2 | $3.55 | Dec 17, 2018 | M | 25,002 | D | — | Feb 28, 2022 | Common Stock | 25,002 | 74,998 | D |
| Stock option (right to buy)F2 | $9.86 | Dec 17, 2018 | M | 11,281 | D | — | Feb 19, 2023 | Common Stock | 11,281 | 58,719 | D |
| Stock option (right to buy)F2 | $11.11 | Dec 17, 2018 | M | 9,000 | D | — | Feb 6, 2024 | Common Stock | 9,000 | 36,000 | D |
| Stock option (right to buy)F2 | $5.10 | Dec 17, 2018 | M | 3 | D | — | Feb 4, 2025 | Common Stock | 3 | 86,247 | D |
| Stock option (right to buy)F3 | $3.18 | Dec 17, 2018 | M | 2 | D | — | Feb 4, 2026 | Common Stock | 2 | 86,248 | D |
Explanation of responses
- F1Represents a gift of 84,112 shares to a donor advised fund.
- F2The option is fully vested and immediately exercisable.
- F3Shares subject to this option vest 1/4 annually over a period of four years beginning February 4, 2017.